A consortium led by Kyoto’s iPS Cell Research Institute has shown that erythroblasts derived from human pluripotent stem cells and immortalized by overexpression of c-MYC and BCL-XL allowed for the production of human erythrocytes in large scale.

Sho-ichi HIROSE et al., Stem Cell Reports doi: 10.1016/j.stemcr.2013.10.010